Can precision medicine overcome the limitations of traditional medicine?
Recent innovations in Precision Medicine for enhanced outcomes
Combining deep desk research with insights from industry experts, this report takes a 360-degree view into precision medicine, looking at its evolution, applications in life sciences and healthcare, legislations, policies and frameworks.
DOWNLOAD THE REPORT NOW
We’d love to hear from you!
Have a Query? Get In Touch With Our Industry Experts!
Precision Medicine Breakthroughs
FDA’s CDx Revolution
170
CDx have been approved by the FDA to date.
38%
patients on antidepressants were found to be ineffective in Conventional therapies.
Medicines
50%
arthritis medicines
Cancer
75%
on cancer drugs
FDA’s CDx Revolution
170
CDx have been approved by the FDA to date.
Innovations and cutting edge technologies like Quantum computers could vastly accelerate the analysis of pangenomes – new representations of DNA sequences that capture population diversity data, enabling more precise and individualized genetic insights.
Dig deeper into the SGA’s Healthcare Precision Medicine Industry Report to gain valuable insights into the rapidly evolving world of healthcare.
We’d love to hear from you!
Have a Query? Get In Touch With Our Industry Experts!
To know more about our
Healthcare Research and Analytics Solutions
Precision Medicine is a transformative approach to healthcare, tailoring treatments to each patient’s genetic, environmental, and lifestyle variations.
FAD approved medicines
DOWNLOAD REPORT
Companion Diagnostics (CDX)
We’d love to hear from you!
Have a Query? Get In Touch With Our Industry Experts!
ABOUT US
Your Comprehensive Support Partner for Precision Medicine
SGA offers end-to-end support for companies in precision medicine through a range of specialized services. We assist them in estimating expected product demand using quantitative and qualitative market research for HCPs, patients, and caregivers. SGA’s REAL forecast methodology further helps project future product potential for the next 5–10 years, complemented by dynamic dashboards for executive visualization. With our pricing benchmark analysis, we identify the overall/annual cost of therapy for competitors as well as analogs and support strategy for penetration in emerging and non-innovator-friendly markets.
Additionally, SGA’s supply chain research and analytics assist in identifying optimal vendors and streamlining logistics, ensuring efficient supply chain management.
SGA offers automation-powered and decision-oriented research expertise required to succeed in this rapidly evolving market.
Our Contributors
Our team is dedicated to building a robust Life Sciences and Healthcare practice, with a strong emphasis on insights and analytics to drive innovation and excellence.
